SOFIE Co. dba SOFIE

Form 483 issued August 11, 2023 · Totowa, New Jersey

Inspection
Jul 19 – Aug 11, 2023
Investigator
Cadre X. Bees
Observations
4
Pages
6
FEI number
3008415560

In short: On August 11, 2023, FDA issued a Form 483 with 4 observations to SOFIE Co. dba SOFIE in Totowa, New Jersey (FEI 3008415560) after an inspection that ran Jul 19 – Aug 11, 2023. The investigator was Cadre X. Bees.

What FDA observed

Preview: the opening words of each observation
  1. 01

    Your facilities are not adequate to ensure the prevention of contamination of equipment or product by…

  2. 02
    21 CFR 212.80(d)

    Labeling and packaging operations for PET drug products were not controlled to prevent…

  3. 03
    21 CFR 212.100(b)

    Your complaint procedures do not include an investigation to determine the…

  4. 04
    21 CFR 212.71(b)

    You did not document for a PET drug product that…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at SOFIE Co. dba SOFIE?

FDA listed 4 observations on this Form 483. The opening words of each observation are shown on this page.

Who inspected SOFIE Co. dba SOFIE?

Cadre X. Bees is named on this Form 483, for the inspection of Jul 19 – Aug 11, 2023. Each investigator has a profile showing what they cite most.

When was SOFIE Co. dba SOFIE inspected by FDA?

The inspection ran Jul 19 – Aug 11, 2023, and the Form 483 is dated August 11, 2023.

How do I get the full Form 483 for SOFIE Co. dba SOFIE?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free